| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50090-6369-0 | 50090-6369 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | TABLET, COATED | ORAL | 20230210 | N/A | ANDA | ANDA040750 | A-S Medication Solutions | SPIRONOLACTONE | 25 mg/1 | 100 TABLET, COATED in 1 BOTTLE (50090-6369-0) |
| 50090-6369-1 | 50090-6369 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | TABLET, COATED | ORAL | 20230216 | N/A | ANDA | ANDA040750 | A-S Medication Solutions | SPIRONOLACTONE | 25 mg/1 | 30 TABLET, COATED in 1 BOTTLE (50090-6369-1) |
| 50090-6369-6 | 50090-6369 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | TABLET, COATED | ORAL | 20230216 | N/A | ANDA | ANDA040750 | A-S Medication Solutions | SPIRONOLACTONE | 25 mg/1 | 90 TABLET, COATED in 1 BOTTLE (50090-6369-6) |